ZNTL logo

Zentalis Pharmaceuticals (ZNTL)

Profile

Full Name

Zentalis Pharmaceuticals, Inc.

Ticker Symbol

ZNTL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 3, 2020

Indexes

Not included

Website

http://zentalis.com

Employees

166

Key Details

Price

$1.27(+4.10%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$67.42M

Annual EPS

-$2.33(+47.87% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.27
ZNTL price is $1.27

30-Day Relative Volume

0.82
ZNTL 30-day relative volume is 0.82

Price Performance

Price Most recent change

+4.1%
ZNTL price was up +4.1% on Apr 15, 2025

Price YTD change

-58.09%
ZNTL price is down -58.09% since January 1st

Price 1-year change

-90.14%
ZNTL price is down -90.14% year-on-year

Price 3-year change

-95.2%
ZNTL price is down -95.2% over the past 3 years

Price Range

Price All-time high

$87.19
ZNTL price is currently -98.54% below its historical high of $87.19

Price 3-year low

$1.01
ZNTL price is currently +25.74% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$91.20M
ZNTL market capitalization is $91.20 million

Market cap 3-year change

-92.46%
ZNTL market capitalization is down -92.46% over the past 3 years

Market cap All-time high

$3.83B
ZNTL market capitalization is currently -97.62% below its historical high of $3.83 billion

Market cap sector rank

47.29%
ZNTL market capitalization is higher than 47.29% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.13%
ZNTL shares outstanding is up +1.13% year-on-year

Shares Outstanding 3-Year Change

+57.22%
ZNTL shares outstanding is up +57.22% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.51
ZNTL beta is 1.51

200-day SMA

$2.95
ZNTL price is currently -56.89% below its 200-day simple moving average

50-day SMA

$1.83
ZNTL price is currently -30.54% below its 50-day simple moving average

RSI

37.99
ZNTL 14-day relative strength index is 37.99

Volume

0.82
ZNTL 30-day relative volume is 0.82

ATR

$0.15
ZNTL average true range is $0.15

10-day Historical Volatility

115.95%
ZNTL 10-day historical volatility is 115.95%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$67.42M
ZNTL annual revenue is $67.42 million

Revenue Analysts estimate

-
ZNTL annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ZNTL annual revenue 1-year change is unknown

Revenue Sector rank

51.4%
ZNTL annual revenue is higher than 51.4% of companies in Healthcare sector

EPS

EPS

-$2.33
ZNTL annual earnings per share is -$2.33

EPS Analysts estimate

-$2.25
ZNTL annual earnings per share is currently +3.48% higher than the consensus analysts' forecast

EPS 1-year change

+47.87%
ZNTL annual earnings per share is up +47.87% year-on-year

EPS Sector rank

35.71%
ZNTL annual earnings per share is higher than 35.71% of companies in Healthcare sector

Profit

Gross profit

-
ZNTL annual gross profit value is unknown

Gross margin

-
ZNTL annual gross profit margin value is unknown

Operating profit

-$187.46M
ZNTL annual operating income is -$187.46 million

Operating margin

-278.02%
ZNTL annual operating profit margin is -278.02%

Net income

-$165.84M
ZNTL annual net profit is -$165.84 million

Net margin

-245.96%
ZNTL annual net profit margin is -245.96%

Expenses

Total expenses

$254.88M
ZNTL annual total expenses is $254.88 million

Operating expenses

$254.88M
ZNTL annual total operating expenses is $254.88 million

Cost of goods sold

-
ZNTL annual cost of goods sold value is unknown

Selling, general & administrative expenses

$87.11M
ZNTL annual SGA is $87.11 million

Depreciation and amortization

$1.29M
ZNTL annual depreciation & amortization is $1.29 million

Interest expense

-
ZNTL annual interest expense value is unknown

Income tax

$177.00K
ZNTL annual income tax is $177.00 thousand

EBIT & EBITDA

EBIT

-$187.46M
ZNTL annual earnings before interest & taxes is -$187.46 million

EBITDA

-$186.17M
ZNTL annual EBITDA is -$186.17 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$430.34M
ZNTL annual total assets is $430.34 million

Non current assets

$44.27M
ZNTL annual long term assets is $44.27 million

Current assets

$386.07M
ZNTL annual total current assets is $386.07 million

Cash and cash equivalents

$33.90M
ZNTL annual cash & cash equivalents is $33.90 million

Accounts receivable

-
ZNTL annual accounts receivable value is unknown

Inventory

-
ZNTL annual inventory value is unknown

Liabilities

Total liabilities

$93.15M
ZNTL annual total liabilities is $93.15 million

Long term liabilities

$40.43M
ZNTL annual total long term liabilities is $40.43 million

Current liabilities

$52.73M
ZNTL annual total current liabilities is $52.73 million

Accounts payable

$7.44M
ZNTL annual accounts payable is $7.44 million

Debt

Total debt

$39.58M
ZNTL annual total debt is $39.58 million

Total debt 1-year change

-8.28%
ZNTL annual total debt is down -8.28% year-on-year

Long term debt

$39.58M
ZNTL annual long term debt is $39.58 million

Short term debt

-
ZNTL annual short term debt value is unknown

Equity & Capital

Shareholders equity

$337.19M
ZNTL annual stockholders equity is $337.19 million

Book value

$337.19M
ZNTL annual book value is $337.19 million

Retained earnings

-$1.05B
ZNTL annual retained earnings is -$1.05 billion

Working capital

$333.34M
ZNTL annual working capital is $333.34 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$170.86M
ZNTL annual cash flow from operations is -$170.86 million

Cash from operations 1-year change

+17.79%
ZNTL annual cash flow from operations is up +17.79% year-on-year

Cash from investing

$176.56M
ZNTL annual cash flow from investing activities is $176.56 million

Cash from investing 1-year change

+497.14%
ZNTL annual cash flow from investing activities is up +497.14% year-on-year

Cash from financing

$108.00K
ZNTL annual cash flow from financing activities is $108.00 thousand

Cash from financing 1-year change

-99.95%
ZNTL annual cash flow from financing activities is down -99.95% year-on-year

CAPEX

CAPEX

$221.00K
ZNTL annual capital expenditures is $221.00 thousand

CAPEX 1-year change

-62.09%
ZNTL annual capital expenditures is down -62.09% year-on-year

Free Cash Flow

Free cash flow

-$171.08M
ZNTL annual free cash flow is -$171.08 million

Free cash flow 1-year change

+17.91%
ZNTL annual free cash flow is up +17.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ZNTL annual gross profit margin value is unknown

Operating margin

-278.02%
ZNTL annual operating profit margin is -278.02%

Net margin

-245.96%
ZNTL annual net profit margin is -245.96%

ROA & ROE

ROA

-33.77%
ZNTL annual return on assets is -33.77%

ROE

-42.82%
ZNTL annual return on equity is -42.82%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ZNTL price to earnings ratio value is unknown

PE ratio Sector rank

-
ZNTL price to earnings ratio is unknown

PB Ratio

PB ratio

0.27
ZNTL price to book ratio is 0.27

PB ratio Sector rank

21.98%
ZNTL price to book ratio is higher than 21.98% of companies in Healthcare sector

PS Ratio

PS ratio

1.35
ZNTL price to sales ratio is 1.35

PS ratio Sector rank

33.08%
ZNTL price to sales ratio is higher than 33.08% of companies in Healthcare sector

Enterprise value

Enterprise value

$96.88M
ZNTL enterprise value is $96.88 million

Enterprise value Sector rank

49.88%
ZNTL enterprise value is higher than 49.88% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.52
ZNTL EV/EBITDA is -0.52

EV/EBITDA Sector rank

51.26%
ZNTL EV/EBITDA is higher than 51.26% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.32
ZNTL annual current ratio is 7.32

Quick ratio

-
ZNTL annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ZNTL annual debt to equity ratio is 0.00

Interest coverage ratio

-
ZNTL annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ZNTL piotroski f-score value is unknown

Altman Z-Score

-3.19
ZNTL altman z-score is -3.19

Analyst ratings

Recent major analysts updates

Mar 28, 25 Wedbush
Neutral
Mar 27, 25 HC Wainwright & Co.
Buy
Mar 17, 25 HC Wainwright & Co.
Buy
Jan 30, 25 Wells Fargo
Equal-Weight
Jan 29, 25 HC Wainwright & Co.
Buy
Jan 28, 25 UBS
Neutral
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 15, 24 Guggenheim
Buy
Sep 16, 24 Oppenheimer
Outperform
Aug 12, 24 Wedbush
Neutral

Institutional Ownership

Similar stocks

ORMP logo
Oramed Pharmaceuticals (ORMP)
ANIX logo
Anixa Biosciences (ANIX)
Climb Bio (CLYM)
PROK logo
ProKidney (PROK)
COYA logo
Coya Therapeutics (COYA)
Genelux (GNLX)
PLRX logo
Pliant Therapeutics (PLRX)
OPTN logo
OptiNose (OPTN)
MBOT logo
Microbot Medical (MBOT)
  • What is the ticker symbol for Zentalis Pharmaceuticals?
  • Does Zentalis Pharmaceuticals pay dividends?
  • What sector is Zentalis Pharmaceuticals in?
  • What industry is Zentalis Pharmaceuticals in?
  • What country is Zentalis Pharmaceuticals based in?
  • When did Zentalis Pharmaceuticals go public?
  • Is Zentalis Pharmaceuticals in the S&P 500?
  • Is Zentalis Pharmaceuticals in the NASDAQ 100?
  • Is Zentalis Pharmaceuticals in the Dow Jones?
  • When was Zentalis Pharmaceuticals's last earnings report?
  • When does Zentalis Pharmaceuticals report earnings?
  • Should I buy Zentalis Pharmaceuticals stock now?

What is the ticker symbol for Zentalis Pharmaceuticals?

The ticker symbol for Zentalis Pharmaceuticals is NASDAQ:ZNTL

Does Zentalis Pharmaceuticals pay dividends?

No, Zentalis Pharmaceuticals does not pay dividends

What sector is Zentalis Pharmaceuticals in?

Zentalis Pharmaceuticals is in the Healthcare sector

What industry is Zentalis Pharmaceuticals in?

Zentalis Pharmaceuticals is in the Biotechnology industry

What country is Zentalis Pharmaceuticals based in?

Zentalis Pharmaceuticals is headquartered in United States

When did Zentalis Pharmaceuticals go public?

Zentalis Pharmaceuticals's initial public offering (IPO) was on April 3, 2020

Is Zentalis Pharmaceuticals in the S&P 500?

No, Zentalis Pharmaceuticals is not included in the S&P 500 index

Is Zentalis Pharmaceuticals in the NASDAQ 100?

No, Zentalis Pharmaceuticals is not included in the NASDAQ 100 index

Is Zentalis Pharmaceuticals in the Dow Jones?

No, Zentalis Pharmaceuticals is not included in the Dow Jones index

When was Zentalis Pharmaceuticals's last earnings report?

Zentalis Pharmaceuticals's most recent earnings report was on Mar 26, 2025

When does Zentalis Pharmaceuticals report earnings?

The next expected earnings date for Zentalis Pharmaceuticals is May 7, 2025

Should I buy Zentalis Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page